Bupropion (Zyban)
Is It Right for You?
A complete guide to Bupropion (Zyban) — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Bupropion (Zyban)?
Zyban is the brand name for bupropion hydrochloride, an atypical antidepressant repurposed as a first-line aid for smoking cessation. It is an aminoketone that inhibits the neuronal reuptake of norepinephrine and dopamine — two neurotransmitters deeply involved in the brain's reward and addiction pathways. By modulating these pathways, bupropion reduces nicotine cravings and diminishes the rewarding properties of cigarettes, making smoking cessation more achievable.
Bupropion was originally developed and licensed as an antidepressant (under the brand name Wellbutrin), and its efficacy in smoking cessation was discovered serendipitously. As Zyban, it is licensed specifically for smoking cessation support in adults as part of a comprehensive smoking cessation programme that includes motivational support and behavioural strategies.
Treatment begins 1 to 2 weeks before the target quit date, allowing bupropion to reach therapeutic blood levels before cessation is attempted. The standard course is 7 to 9 weeks. Zyban approximately doubles the chance of successful long-term smoking cessation compared to placebo.
Zyban is a prescription-only medication in the UK. A licensed clinician must assess your medical history, seizure risk, and current medications before it can be prescribed — which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Zyban Used For?
Zyban is licensed for:
as an aid to motivation and behavioural support in adults who are medically dependent on nicotine and motivated to stop smoking. It is most effective when combined with structured support (counselling, NHS Stop Smoking Services, motivational interviewing).
Although bupropion has antidepressant properties, Zyban is prescribed specifically for its efficacy in smoking cessation. Improvement in mood reported by some patients during treatment is likely attributable to both the direct antidepressant effects and the psychological benefits of successfully stopping smoking, rather than an intended antidepressant action.
How Does Zyban Work?
Bupropion selectively inhibits the neuronal reuptake of norepinephrine and dopamine — without significantly affecting serotonin reuptake (distinguishing it from SSRIs and SNRIs). It also acts as a non-competitive antagonist at nicotinic acetylcholine receptors (nAChRs), the same receptors through which nicotine exerts its rewarding and addictive effects.
In the context of smoking cessation, these mechanisms work in several complementary ways:
Dopaminergic Activity — Nicotine addiction is fundamentally driven by nicotine's stimulation of the brain's mesolimbic dopamine reward system — the "reward pathway." Bupropion's dopamine-enhancing effects partially substitute for nicotine's dopaminergic reward, reducing the drive to smoke and alleviating some withdrawal symptoms.
Noradrenergic Activity — Enhanced norepinephrine activity helps reduce the anxiety, irritability, and restlessness associated with nicotine withdrawal.
Nicotinic Acetylcholine Receptor Antagonism — By blocking nAChRs, bupropion directly reduces the rewarding response to any cigarettes smoked during the quit period, making smoking less satisfying and undermining the habit-reinforcing aspects of nicotine.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Take in the morning — the first dose is taken once daily in the morning. If a twice-daily schedule is being followed, take the second dose in the early afternoon (ideally at least 8 hours after the morning dose) to avoid insomnia.
Do not take the second dose late in the evening — bupropion can cause insomnia and should not be taken within 6 hours of bedtime.
Swallow tablets whole — do not crush or chew; this destroys the modified-release mechanism.
Allow 7 to 14 days before your quit date to allow bupropion to reach effective therapeutic blood levels and begin its effects on craving pathways before you stop smoking.
Combine with support services — Zyban is most effective as part of a comprehensive cessation programme. Enrol with NHS Stop Smoking Services or equivalent support.
Side Effects of Zyban
Bupropion is generally well tolerated. The most common side effects reflect its noradrenergic and dopaminergic mechanisms.
- Insomnia
- Dry mouth
- Headache
- Nausea
- Dizziness
- Tremor
- Constipation
- Anxiety or agitation
- Concentration difficulties
- Seizures — the most clinically important serious adverse effect; bupropion lowers the seizure threshold in a dose-dependent manner; risk is approximately 0.1% at recommended doses; significantly higher in patients with predisposing factors (see contraindications)
- Severe hypersensitivity reactions — anaphylaxis, angioedema, severe skin reactions (Stevens-Johnson Syndrome); rare
- Neuropsychiatric effects — agitation, depression, suicidal ideation, hostility, aggression, behavioural changes; patients and carers should be alert to mood or behaviour changes
- Activation of mania / bipolar disorder — in patients with undiagnosed or known bipolar disorder
- Hypertension — bupropion can raise blood pressure, particularly in the context of nicotine withdrawal; blood pressure monitoring is advisable
Bupropion is associated with a dose-dependent risk of seizures. This risk is significantly elevated in patients with a history of epilepsy or seizures, current or recent use of high-dose alcohol or benzodiazepines (risk of withdrawal seizures), anorexia nervosa or bulimia nervosa (electrolyte imbalances), or those taking other medications that lower the seizure threshold. These are contraindications or require extreme caution. Always disclose your full medical history before starting Zyban.
Drug Interactions
Always disclose all medications and supplements to your clinician or pharmacist.
Additive seizure risk; use with caution or avoid.
Heavy alcohol use or abrupt cessation of regular alcohol consumption increases seizure risk with bupropion. Patients are advised to minimise alcohol consumption during treatment.
May be used in combination with bupropion (NRT + bupropion is more effective than either alone for smoking cessation), but combination may increase blood pressure; monitor.
Additive dopaminergic effects; increased risk of side effects including agitation, restlessness, and nausea.
Important Warnings
Zyban is contraindicated in: patients with a current or prior history of seizures or epilepsy; patients with a current or prior diagnosis of anorexia nervosa or bulimia nervosa; patients undergoing abrupt alcohol or benzodiazepine withdrawal; patients taking other medications that significantly lower the seizure threshold. Inform your clinician of all neurological history and all medications before starting.
Patients (and carers/family members) should be alert to changes in mood, behaviour, agitation, depression, or suicidal thoughts during treatment. These symptoms may occur during nicotine withdrawal or as a direct drug effect, and require immediate clinical review.
Zyban is not recommended during pregnancy. If pregnancy is confirmed during treatment, discontinue immediately. Smoking cessation through behavioural support and nicotine replacement therapy should be offered as safer alternatives.
Bupropion can raise blood pressure. Blood pressure should be monitored before and during treatment, particularly in patients with pre-existing hypertension.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Zyban FAQs
Clinical evidence shows that bupropion approximately doubles the rate of long-term smoking abstinence compared to placebo. In controlled trials, approximately 20–30% of patients who use bupropion remain smoke-free at 12 months, compared to approximately 10–15% with placebo. Combining bupropion with nicotine replacement therapy and structured behavioural support increases success rates further.
Varenicline (Champix) is generally considered the most effective pharmacological aid to smoking cessation — superior to both bupropion and nicotine replacement therapy as monotherapy. However, Champix had a complex availability history in the UK due to contamination issues. Bupropion (Zyban) remains an important, effective, and well-established alternative. Your clinician will discuss which option is most appropriate for your clinical situation.
Yes — you should continue to smoke as normal during the first week of Zyban treatment. The target quit date is set for the beginning of the second week, by which time bupropion has reached therapeutic levels and begun to modify reward and withdrawal pathways. Attempting to quit on the first day of bupropion, before therapeutic levels are achieved, reduces efficacy.
Bupropion is an antidepressant by mechanism, and many patients report improvement in mood during Zyban treatment — both from the drug's direct effect and from the psychological benefits of quitting smoking. However, as with any psychoactive medication, mood changes including low mood, agitation, or unusual behaviour can occur in a small number of patients. Report any concerning mood changes to your clinician promptly.